Why Estonia Works for Biotech / Life Sciences
Family viability (100/100) is a genuine strength for Estonia - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 55 (NYC = 100), with a comfortable family monthly budget of $4K. Safety scores 79/100. International schools are available, and healthcare quality scores 72/100 with private insurance running approximately $200/month.
Operational ease (96/100) makes Estonia practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated easy. Company formation takes approximately 1 days at a cost of around $200, with annual compliance costs around $800. Full foreign ownership is permitted - no local partner required. IP protection quality is rated strong, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.
Funding access (95/100) is a standout for Estonia Biotech / Life Sciences companies. The local market has 35 active VC funds, with average seed checks of $600K. Government grant programs include Enterprise Estonia Development Grant ($200K) and Startup Estonia Support ($10K). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.